These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


656 related items for PubMed ID: 33372687

  • 21. Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment.
    Jiang XY, Zhu XS, Xu HY, Zhao ZX, Li SY, Li SZ, Cai JH, Cao JM.
    Acta Pharmacol Sin; 2017 Jul; 38(7):1048-1058. PubMed ID: 28344324
    [Abstract] [Full Text] [Related]

  • 22. Schisandrin B suppresses osteosarcoma lung metastasis in vivo by inhibiting the activation of the Wnt/β‑catenin and PI3K/Akt signaling pathways.
    Wang Y, Chen J, Huang Y, Yang S, Tan T, Wang N, Zhang J, Ye C, Wei M, Luo J, Luo X.
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
    [Abstract] [Full Text] [Related]

  • 23. Diallyl Trisulfide Inhibits Growth of NCI-H460 in Vitro and in Vivo, and Ameliorates Cisplatin-Induced Oxidative Injury in the Treatment of Lung Carcinoma in Xenograft Mice.
    Jiang X, Zhu X, Liu N, Xu H, Zhao Z, Li S, Li S, Cai J, Cao J.
    Int J Biol Sci; 2017 Mar; 13(2):167-178. PubMed ID: 28255269
    [Abstract] [Full Text] [Related]

  • 24. Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line.
    Wang Z, Xia Q, Cui J, Diao Y, Li J.
    Oncol Rep; 2014 Jun; 31(6):2720-6. PubMed ID: 24788927
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway.
    Wang HC, Chu YL, Hsieh SC, Sheen LY.
    Environ Toxicol; 2017 Nov; 32(11):2352-2359. PubMed ID: 28741790
    [Abstract] [Full Text] [Related]

  • 28. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
    ShuoWang, Song Z, Gong X, Ou C, Zhang W, Wang J, Yao C, Qin S, Yan B, Li Q, Wei K, Hou X, Zhou X, Miao J.
    J Ethnopharmacol; 2021 May 10; 271():113879. PubMed ID: 33524509
    [Abstract] [Full Text] [Related]

  • 29. Lactate dehydrogenase downregulation mediates the inhibitory effect of diallyl trisulfide on proliferation, metastasis, and invasion in triple-negative breast cancer.
    Cheng SY, Yang YC, Ting KL, Wen SY, Viswanadha VP, Huang CY, Kuo WW.
    Environ Toxicol; 2017 Apr 10; 32(4):1390-1398. PubMed ID: 27566995
    [Abstract] [Full Text] [Related]

  • 30. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling.
    Li Y, Zhang J, Zhang L, Si M, Yin H, Li J.
    Carcinogenesis; 2013 Jul 10; 34(7):1601-10. PubMed ID: 23430952
    [Abstract] [Full Text] [Related]

  • 31. Evodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway.
    Zhou Y, Hu J.
    Med Sci Monit; 2018 Aug 23; 24():5874-5880. PubMed ID: 30135419
    [Abstract] [Full Text] [Related]

  • 32. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
    Cheng Z, Guo Y, Yang Y, Kan J, Dai S, Helian M, Li B, Xu J, Liu C.
    Oncol Rep; 2016 Aug 23; 36(2):1023-9. PubMed ID: 27279040
    [Abstract] [Full Text] [Related]

  • 33. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
    Li D, Yang J, Ma H, Sun C, Feng R.
    J Cell Biochem; 2018 Dec 23; 119(12):9899-9909. PubMed ID: 30132953
    [Abstract] [Full Text] [Related]

  • 34. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
    Qu Q, He Z, Jiang Y, Lu D, Long X, Ding Y, Xu B, He X.
    Med Sci Monit; 2019 Oct 07; 25():7527-7537. PubMed ID: 31589596
    [Abstract] [Full Text] [Related]

  • 35. Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells.
    Ma HB, Huang S, Yin XR, Zhang Y, Di ZL.
    World J Gastroenterol; 2014 Jan 07; 20(1):193-203. PubMed ID: 24415872
    [Abstract] [Full Text] [Related]

  • 36. Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway.
    He W, Fu Y, Zheng Y, Wang X, Liu B, Zeng J.
    BMC Cancer; 2021 Feb 06; 21(1):125. PubMed ID: 33549034
    [Abstract] [Full Text] [Related]

  • 37. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
    Long XH, Zhang GM, Peng AF, Luo QF, Zhang L, Wen HC, Zhou RP, Gao S, Zhou Y, Liu ZL.
    Oncol Rep; 2014 Jan 06; 31(1):328-34. PubMed ID: 24172910
    [Abstract] [Full Text] [Related]

  • 38. Pseudomonas aeruginosa mannose-sensitive hemagglutinin inhibits proliferation and invasion via the PTEN/AKT pathway in HeLa cells.
    Yin TQ, Ou-Yang X, Jiao FY, Huang LP, Tang XD, Ren BQ.
    Oncotarget; 2016 Jun 14; 7(24):37121-37131. PubMed ID: 27206797
    [Abstract] [Full Text] [Related]

  • 39. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z, Yang J, Yang Y, Wang X, Chen G, Shi A, Lu Y, Jia S, Kang X, Lu L.
    Phytomedicine; 2020 Mar 14; 68():153186. PubMed ID: 32088353
    [Abstract] [Full Text] [Related]

  • 40. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y, Cheng H, Li W, Wu H, Yang Y.
    Int J Cancer; 2019 Aug 15; 145(4):1068-1082. PubMed ID: 30761524
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 33.